Sham Controlled Clinical Trial of Renal Denervation in Patients With Resistant Hypertension

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 105 participants.

Also called NCT02444442

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 105 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02444442
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Australia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02444442. Randomized; double masking; primary purpose treatment. Start 2015-06 (registry gives no type); primary completion 2020-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sham Controlled Clinical Trial of Renal Denervation in Patients With Resistant Hypertension
Condition
Hypertension
Intervention (Device)
Renal Denervation
Intervention (Other)
Sham control
Lead sponsor
Baker Heart and Diabetes Institute (class: other)

Record details

Record id
cardio:ct-nct02444442
Content hash
ca1ce5b6f260af64e8a195088fe74bf06146b958a7791e9d1ec7475c2c82200a